This inventor holds 2 USPTO granted patents. Top assignees: Harvard College, The Brigham and Women's Hospital, Inc.. Active years: 1998-1999.
Company Filing History:
2 out of 3,071 
2 out of 1,424 
Years Active: 1998-1999
Title: Ludwig Thierfelder: Innovator in Hypertrophic Cardiomyopathy Detection
Introduction
Ludwig Thierfelder is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of genetics, particularly in the detection of mutations associated with hypertrophic cardiomyopathy (HC). With a total of 2 patents, his work has the potential to impact the diagnosis and treatment of this serious heart condition.
Latest Patents
Thierfelder's latest patents focus on methods for detecting mutations related to hypertrophic cardiomyopathy. These methods involve providing DNA that encodes a sarcomeric thin filament protein, such as alpha-tropomyosin or cardiac troponin T. The detection process identifies the presence or absence of mutations in the amplified product associated with HC. Additionally, his inventions include methods for diagnosing familial hypertrophic cardiomyopathy (FHC) by analyzing DNA samples from subjects. The diagnosis is based on identifying mutations in the sarcomeric thin filament proteins that indicate the disease. Furthermore, alternative methods for diagnosing HC involve obtaining samples of sarcomeric proteins and detecting abnormalities as indicators of the condition. Thierfelder's patents also encompass kits for diagnosing HC and methods for treating the disease.
Career Highlights
Throughout his career, Thierfelder has worked with prestigious institutions, including Brigham and Women's Hospital and Harvard College. His experience in these organizations has allowed him to collaborate with leading experts in the field of cardiology and genetics.
Collaborations
Some of Thierfelder's notable coworkers include Christine E. Seidman and Jonathan G. Seidman. Their collaborative efforts have contributed to advancements in understanding and diagnosing hypertrophic cardiomyopathy.
Conclusion
Ludwig Thierfelder's innovative work in the detection of mutations associated with hypertrophic cardiomyopathy showcases his commitment to improving medical diagnostics. His contributions have the potential to enhance the lives of individuals affected by this condition.